Quick Overview: Our co-hosts discuss the currently active & accruing Dr. Arvind Dasari (Study PI) and Dr. Thomas George (GI Cancer Committee Chair (Colorectal)) discuss the Drs. Von Ah, Ganz, and McDonald discuss the upcoming trial (as of 12/5/2023)

Nrg Gi008 The Circulate Na - Detailed Overview & Context

Our co-hosts discuss the currently active & accruing Dr. Arvind Dasari (Study PI) and Dr. Thomas George (GI Cancer Committee Chair (Colorectal)) discuss the Drs. Von Ah, Ganz, and McDonald discuss the upcoming trial (as of 12/5/2023) Scott Kopetz, MD, PhD, FASCO, The University of Texas MD Anderson Cancer Center, Houston, TX, highlights the potential of ... Drs. Diane Von Ah and Patricia Ganz discuss the Our co-hosts sit with Drs. Ross Abrams and Karyn Goodman to discuss the results of

For Pancreatic Cancer Awareness Month, we discuss the recently activated Arvind Dasari, MD, MS, The University of Texas MD Anderson Cancer Center, Houston, TX, outlines the Dr Stacey A Cohen from the University of Washington in Seattle, Dr Arvind Dasari from The University of Texas MD Anderson ... Van K. Morris, MD, University of Texas MD Anderson Cancer Center, Houston, TX, presents the prospective Phase II/III clinical trial ... "It would not have been a death sentence." Colon cancer is one of the most preventable cancers, and that's the message Jamie ... Arvind Dasari, MD, MS, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses the

Dr. Dunne shared his expertise on, the integration of ctDNA in treatment decisions for colon cancer patients. Then the ...

Photo Gallery

NRG-GI008, the CIRCULATE NA Study, with Drs. Dasari and George
NRG-GI008, the "CIRCULATE-North America" Study Overview
NRG Oncology Gastrointestinal Colorectal Committee - 2023
Overview Interview of NRG-GI012 for Sites
NRG-CC011 Pre-Activation Webinar
What is the future role of ctDNA as a biomarker in colorectal cancer?
NRG-CC009 Interview
NRG-CC011 Study Interview for Sites
NRG-RTOG 0848 Results in Pancreatic Cancer
NRG-GI011 "LAP100" in Pancreatic Cancer
CIRCULATE-US: investigating the use of ctDNA to detect MRD
Colorectal Cancer — A Roundtable Discussion on the Use of Molecular Residual Disease Analysis
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored